Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SOBI.ST Stock Summary
Top 10 Correlated ETFs
SOBI.ST
In the News
SOBI.ST Financial details
Company Rating
Strong Buy
Market Cap
68.34B
Income
3.16B
Revenue
19.1B
Book val./share
93.93
Cash/share
0.67
Dividend
-
Dividend %
-
Employees
1.61K
Optionable
No
Shortable
Yes
Earnings
18 Jul 2023
P/E
21.59
Forward P/E
-
PEG
-6.34
P/S
3.58
P/B
2.45
P/C
343.88
P/FCF
160.8
Quick Ratio
0.01
Current Ratio
0.7
Debt / Equity
0.94
LT Debt / Equity
0.11
-
-
EPS (TTM)
5.99
EPS next Y
-
EPS next Q
-
EPS this Y
-1.76%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-0.11%
Revenue last 5Y
15.51%
Revenue Q/Q
-12.54%
EPS Q/Q
-
-
-
-
-
SMA20
-11.32%
SMA50
-2.08%
SMA100
7.31%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
12%
ROC
0.11%
Gross Margin
77%
Oper. Margin
23%
Profit Margin
17%
Payout
-
Shs Outstand
296.61M
Shs Float
188.35M
-
-
-
-
Target Price
-
52W Range
199.1-273.8
52W High
-15.6%
52W Low
+15.78%
RSI
40
Rel Volume
0.58
Avg Volume
349.15K
Volume
203.86K
Perf Week
-2.04%
Perf Month
-11.79%
Perf Quarter
1.63%
Perf Half Y
7.41%
-
-
-
-
Beta
0.367891
-
-
Volatility
3.6%, 14.69%
Prev Close
-0.17%
Price
230.4
Change
-1.96%
SOBI.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 33.91 | 48.69 | 51.79 | 52.63 | 63.56 | |
Net income per share | 8.97 | 11.29 | 11.01 | 9.08 | 8.92 | |
Operating cash flow per share | 7.76 | 12.42 | 17.7 | 18.54 | 15.78 | |
Free cash flow per share | 5.61 | -20.89 | 4.62 | 17.29 | 10.78 | |
Cash per share | 11.13 | 2.52 | 1.37 | 3.54 | 4.6 | |
Book value per share | 33.54 | 57.85 | 68.57 | 78.64 | 89.73 | |
Tangible book value per share | -4.15 | -70 | -63.07 | -51.58 | -45.63 | |
Share holders equity per share | 33.54 | 57.85 | 68.57 | 78.64 | 89.73 | |
Interest debt per share | 0.22 | 57.41 | 50.99 | 38.38 | 32.33 | |
Market cap | 54.15B | 45.21B | 48.94B | 54.61B | 63.76B | |
Enterprise value | 51.15B | 61.04B | 63.11B | 64.47B | 71.5B | |
P/E ratio | 22.4 | 13.68 | 15.08 | 20.39 | 24.17 | |
Price to sales ratio | 5.92 | 3.17 | 3.21 | 3.52 | 3.39 | |
POCF ratio | 25.9 | 12.44 | 9.39 | 9.98 | 13.67 | |
PFCF ratio | 35.8 | -7.4 | 35.93 | 10.71 | 20 | |
P/B Ratio | 5.99 | 2.67 | 2.42 | 2.35 | 2.4 | |
PTB ratio | 5.99 | 2.67 | 2.42 | 2.35 | 2.4 | |
EV to sales | 5.6 | 4.28 | 4.14 | 4.15 | 3.81 | |
Enterprise value over EBITDA | 14.12 | 10.1 | 10.02 | 11.16 | 11.54 | |
EV to operating cash flow | 24.47 | 16.8 | 12.1 | 11.79 | 15.33 | |
EV to free cash flow | 33.82 | -9.99 | 46.34 | 12.64 | 22.43 | |
Earnings yield | 0.04 | 0.07 | 0.07 | 0.05 | 0.04 | |
Free cash flow yield | 0.03 | -0.14 | 0.03 | 0.09 | 0.05 | |
Debt to equity | 0.9 | 1.7 | 1.39 | 1.1 | 0.98 | |
Debt to assets | 0.47 | 0.63 | 0.58 | 0.52 | 0.49 | |
Net debt to EBITDA | -0.83 | 2.62 | 2.25 | 1.71 | 1.25 | |
Current ratio | 0.95 | 1.28 | 0.78 | 1 | 0.75 | |
Interest coverage | 55.34 | 18.81 | 10.61 | 8.91 | 8.33 | |
Income quality | 0.86 | 1.1 | 1.61 | 1.66 | 1.4 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0.39 | 0.41 | 0.42 | |
Research and developement to revenue | 0.12 | 0.1 | 0.1 | 0.13 | 0.13 | |
Intangibles to total assets | 0.59 | 0.82 | 0.8 | 0.79 | 0.76 | |
Capex to operating cash flow | -0.28 | -2.68 | -0.74 | -0.07 | -0.32 | |
Capex to revenue | -0.06 | -0.68 | -0.25 | -0.02 | -0.08 | |
Capex to depreciation | -1.19 | -6.13 | -1.9 | -0.18 | -0.61 | |
Stock based compensation to revenue | 0 | 0.01 | 0.01 | 0 | 0 | |
Graham number | 82.28 | 121.23 | 130.35 | 126.75 | 134.23 | |
ROIC | 0.23 | 0.08 | 0.08 | 0.07 | 0.06 | |
Return on tangible assets | 0.34 | 0.4 | 0.34 | 0.26 | 0.21 | |
Graham Net | -16.7 | -92.62 | -88.74 | -76.94 | -77.62 | |
Working capital | -349.16M | 1.58B | -2.28B | 17M | -3.65B | |
Tangible asset value | -1.12B | -20.48B | -18.59B | -15.22B | -13.49B | |
Net current asset value | -1.54B | -21.41B | -19.91B | -16.68B | -14.76B | |
Invested capital | 0 | 0.98 | 0.72 | 0.47 | 0.34 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 422.71M | 583.99M | 625M | 563.5M | 905M | |
Average inventory | 1.17B | 1.53B | 2.41B | 3.24B | 3.38B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 73.59 | 74.53 | 64.4 | 58.46 | 95.68 | |
Days of inventory on hand | 194.04 | 193.94 | 345.53 | 358.71 | 254.64 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 4.96 | 4.9 | 5.67 | 6.24 | 3.81 | |
Inventory turnover | 1.88 | 1.88 | 1.06 | 1.02 | 1.43 | |
ROE | 0.27 | 0.2 | 0.16 | 0.12 | 0.1 | |
Capex per share | -2.14 | -33.3 | -13.07 | -1.25 | -5 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 16.69 | 13.12 | 13.51 | 0 | 17.68 | |
Net income per share | 1.84 | 0.87 | 1.52 | 0 | 3.6 | |
Operating cash flow per share | 5.57 | 1.16 | 2.64 | 0 | 6.69 | |
Free cash flow per share | 5.04 | -0.65 | 0.19 | 0 | -4.3 | |
Cash per share | 3.6 | 1.22 | 0.97 | 0 | 0.67 | |
Book value per share | 80.49 | 82.37 | 84.7 | 0 | 93.93 | |
Tangible book value per share | 80.49 | -50.07 | 84.7 | 0 | 93.93 | |
Share holders equity per share | 80.49 | 82.37 | 84.7 | 0 | 93.93 | |
Interest debt per share | 32.77 | 33.38 | 33.95 | 0 | 31.74 | |
Market cap | 65.82B | 65.32B | 63.8B | 0 | 71.55B | |
Enterprise value | 74.53B | 74.82B | 73.7B | 7.74B | 80.59B | |
P/E ratio | 30.3 | 63.3 | 35.37 | 0 | 16.76 | |
Price to sales ratio | 13.36 | 16.85 | 15.95 | 0 | 13.66 | |
POCF ratio | 40.04 | 190.45 | 81.8 | 0 | 36.08 | |
PFCF ratio | 44.26 | -342.01 | 1.14K | 0 | -56.12 | |
P/B Ratio | 2.77 | 2.69 | 2.55 | 0 | 2.57 | |
PTB ratio | 2.77 | 2.69 | 2.55 | 0 | 2.57 | |
EV to sales | 15.13 | 19.3 | 18.43 | 1.29 | 15.38 | |
Enterprise value over EBITDA | 51.01 | 84.25 | 57.67 | 3.13 | 37.34 | |
EV to operating cash flow | 45.33 | 218.13 | 94.48 | 4.08 | 40.64 | |
EV to free cash flow | 50.12 | -391.72 | 1.32K | 4.22 | -63.2 | |
Earnings yield | 0.01 | 0 | 0.01 | 0 | 0.01 | |
Free cash flow yield | 0.02 | 0 | 0 | 0 | -0.02 | |
Debt to equity | 1.05 | 0.99 | 1.03 | 0.98 | 0.94 | |
Debt to assets | 0.51 | 0.5 | 0.51 | 0.49 | 0.48 | |
Net debt to EBITDA | 5.96 | 10.69 | 7.74 | 3.13 | 4.19 | |
Current ratio | 1.03 | 1.02 | 0.88 | 0.75 | 0.7 | |
Interest coverage | -7.61 | 53.83 | -5.18 | 16.66 | 8.85 | |
Income quality | 2.44 | 1.08 | 1.38 | 1.07 | 1.5 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.42 | 0.34 | 0 | 0 | 0.39 | |
Research and developement to revenue | 0.12 | 0.16 | 0.13 | 0.11 | 0.12 | |
Intangibles to total assets | 0.78 | 0.81 | 0.81 | 0.76 | 0.79 | |
Capex to operating cash flow | -0.1 | -1.56 | -0.93 | -0.03 | -1.64 | |
Capex to revenue | -0.03 | -0.14 | -0.18 | -0.01 | -0.62 | |
Capex to depreciation | -0.23 | -0.95 | -1.25 | -0.11 | -4.91 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 57.72 | 40.24 | 53.89 | 0 | 87.24 | |
ROIC | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | |
Return on tangible assets | 0.05 | 0.03 | 0.05 | 0.11 | 0.09 | |
Graham Net | -66.05 | -66.66 | -72.62 | 0 | -81.19 | |
Working capital | 307M | 162M | -1.07B | -3.65B | -4.41B | |
Tangible asset value | -14.51B | -14.79B | -16.43B | -13.49B | -14.52B | |
Net current asset value | -15.69B | -16.06B | -17.77B | -14.76B | -15.78B | |
Invested capital | 0.41 | 0.41 | 0.41 | 0.34 | 0.33 | |
Average receivables | 3.59B | 3.44B | 3.19B | 1.62B | 0 | |
Average payables | 551.5M | 532M | 440M | 806.5M | 938.5M | |
Average inventory | 3.39B | 3.39B | 3.37B | 3.32B | 3.5B | |
Days sales outstanding | 68.49 | 72.61 | 73.1 | 0 | 0 | |
Days payables outstanding | 32.35 | 45.79 | 34.86 | 86.15 | 52.72 | |
Days of inventory on hand | 199.77 | 302.12 | 319.44 | 229.27 | 308.88 | |
Receivables turnover | 1.31 | 1.24 | 1.23 | 0 | 0 | |
Payables turnover | 2.78 | 1.97 | 2.58 | 1.04 | 1.71 | |
Inventory turnover | 0.45 | 0.3 | 0.28 | 0.39 | 0.29 | |
ROE | 0.02 | 0.01 | 0.02 | 0.05 | 0.04 | |
Capex per share | -0.53 | -1.81 | -2.45 | 0 | -11 |
SOBI.ST Frequently Asked Questions
What is Swedish Orphan Biovitrum AB (publ) stock symbol ?
Swedish Orphan Biovitrum AB (publ) is a SE stock and trading under the symbol SOBI.ST
What is Swedish Orphan Biovitrum AB (publ) stock quote today ?
Swedish Orphan Biovitrum AB (publ) stock price is $230.4 today.
Is Swedish Orphan Biovitrum AB (publ) stock public?
Yes, Swedish Orphan Biovitrum AB (publ) is a publicly traded company.